Post-approval studies (Phase 4)Ended earlyNCT01308203
What this trial is testing
Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
Who this might be right for
Coronary Artery DiseaseDyslipidemias
Daniel A. Siniawski 32